Inflammasomes and inflammatory caspases in skin inflammation

Expert Review of Molecular Diagnostics

Volumn 8, Issue 6, 2008, Pages 697-705

  Iversen, Lars ^a   Johansen, Claus ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Contact hypersensitivity; IL 1; Inflammasomes; Inflammatory caspases; Psoriasis; Skin

Indexed keywords

CASPASE; CASPASE 11; CASPASE 12; CASPASE 5; INTERLEUKIN 1BETA CONVERTING ENZYME; MITOGEN ACTIVATED PROTEIN KINASE P38;

ENZYME ACTIVATION; HYPERSENSITIVITY; PROTEIN EXPRESSION; PSORIASIS; REVIEW; SKIN INFLAMMATION;

ANIMALS; CASPASES; ENZYME ACTIVATION; HUMANS; HYPERSENSITIVITY; INFLAMMATION MEDIATORS; MAP KINASE SIGNALING SYSTEM; SKIN DISEASES;

EID: 56049124633     PISSN: 14737159     EISSN: 17448352     Source Type: Journal    
DOI: 10.1586/14737159.8.6.697     Document Type: Review

References (67)

1. Martinon F, Tschopp J. Inflammatory caspases: linking an intracellular innate immune system to autoinflammatory diseases. Cell 117, 561-574 (2004). • Important review linking inflammatory caspases to autoinflammatory diseases.
2. Saleh M, Vaillancourt JP, Graham RK et al. Differential modulation of endotoxin responsiveness by human caspase-12 polymorphisms. Nature 429, 75-79 (2004).
3. Martinon F, Tschopp J. Inflammatory caspases and inflammasomes: master switches of inflammation. Cell Death Differ. 14, 10-22 (2007). • Reviews the role of inflammasomes and inflammatory caspases in innate immunity.
4. Kanneganti TD, Lamkanfi M, Nunez G. Intracellular NOD-like receptors in host defense and disease. Immunity 27, 549-559 (2007).
5. Grabbe S, Schwartz T. Immunoregulatory mechanisms involved in elicitation of allergic contact hypersensitivity. Immunol. Today 19, 37-44 (1998).
6. Nestle FO, Nickoloff BJ. Deepening our understanding of immune sentinels in the skin. J. Clin. Invest. 117, 2382-2385 (2007).
7. + macrophages. J. Clin. Invest. 117, 2517-2525 (2007).
8. Bos JD, De Rie MA, Teunissen MB et al. Psoriasis: dysregulation of innate immunity. Br. J. Dermatol. 152, 1098-1107 (2005).
9. Henseler T, Christophers E. Disease concomitance in psoriasis. J. Am. Acad. Dermatol. 32, 982-986 (1995).
10. Lamkanfi M, Declerq W, Berghe TV et al. Caspases leave the beaten track: caspase-mediated activation of NF-κB. J. Cell Biol. 173, 165-171 (2006).
11. Yamin TT, Ayala JM, Miller DK. Activation of the native 45-kDa precursor form of interleukin-1-converting enzyme. J. Biol. Chem. 271, 13273-13282 (1996).
12. Hentze H, Lin XY, Choi MS et al. Critical role for cathepsin B in mediating caspase-1-dependent interleukin-18 maturation and caspase-1- independent necrosis triggered by the microbial toxin nigericin. Cell Death Differ. 10, 956-968 (2003).
13. Schmitz J, Owyang A, Oldham E et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 23, 479-490 (2005).
14. Thomberry NA, Bull HG, Calaycay JR et al. A novel heterodimeric cysteine protease is required for interleukin-1β processing in monocytes. Nature 356, 768-774 (1992).
15. Li P, Allen H, Banerjee S et al. Mice deficient in IL-1 β-converting enzyme are defective in production of mature IL-1β and resistant to endotoxic shock. Cell 80, 401-411 (1995).
16. Kuida K, Lippke JA, Ku G et al. Altered cytokine export and apoptosis in mice deficient in interleukin-1β converting enzyme. Science 267, 2000-2003 (1995).
17. Gu Y, Kuida K, Tsutsui H et al. Activation of interferon-γ inducing factor mediated by interleukin-1β converting enzyme. Science 275, 206-209 (1997).
18. Ghayur T, Banerjee S, Hugunin M et al. Caspase-1 processes IFN-γ-inducing factor and regulates LPS-induced IFN-γ production. Nature 386, 619-623 (1997).
19. Sansonetti PJ, Phalipon A, Arondel J et al. Caspase-1 activation of IL-1β and IL-18 are essential for Shigella flexneri-induced inflammation. Immunity 22, 669-677 (2000).
20. Tsuji NM, Tsutsui H, Seki E et al. Roles of caspase-1 in Listeria infection in mice. Int. Immunol. 16, 335-343 (2004).
21. Mariathasan S, Weiss DS, Dixit VM et al. Innate immunity against Francisella tularensis is dependent on the ASC/caspase-1 axis. J. Exp. Med. 202, 1043-1049 (2005).
22. Miura M, Zhu H, Rotello R et al. Induction of apoptosis in fibroblasts by IL-1 β-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3. Cell 75, 653-660 (1993).
23. Gurcel L, Abrami L, Girardin S et al. Caspase-1 activation of lipid metabolic pathways in response to bacterial pore-forming toxins promotes cell survival. Cell 126, 1135-1145 (2006).
24. Muhl H, Pfeilschifter J. Interleukin-18 bioactivity: a novel target for immunopharmacological anti-inflammatory intervention. Eur. J. Pharmacol. 500, 63-71 (2004).
25. Koizumi H, Sato-Matsumura KC, Nakamura H et al. Distribution of IL-18 and IL-18 receptor in human skin: various forms of IL-18 are produced in keratinocytes. Arch. Dermatol. Res. 293, 325-333 (2001).
26. Wang S, Miura M, Jung YK et al. Murine caspase-11, an ICE-interacting protease, is essential for the activation of ICE. Cell 92, 501-509 (1998).
27. Ahn EY, Pan G, Vickers SM et al. IFN-γ upregulates apoptosis-related molecules and enhances Fas-mediated apoptosis in human cholangiocarcinoma. Int. J. Cancer 100, 445-451 (2002).
28. Schwartz S Jr, Yamamoto H, Navarro M et al. Frameshift mutations at mononucleotide repeats in caspase-5 and other target genes in endometrial and gastrointestinal cancer of the microsatellite mutator phenotype. Cancer Res. 59, 2995-3002 (1999).
29. Lin XY, Choi MS, Porter AG. Expression ana lysis of the human caspase-1 subfamily reveals specific regulation of the CASP5 gene by lipopolysaccharide and interferon-γ. J. Biol. Chem. 275, 39920-39926 (2000).
30. Yamamoto M, Yaginuma K, Tsutsui H et al. ASC is essential for LPS-induced activation of procaspase-1 independently of TLR-associated signal adaptor molecules. Genes Cells 9, 1055-1067 (2004).
31. Martinon F, Burns K, Tschopp J. The inflammasome: molecular platform triggering activation of inflammatory caspases and processing of proIL-β. Mol. Cell 10, 417-426 (2002).
32. Masumoto J, Taniguchi S, Nakayama J et al. Expression of apoptosis-associated speck-like protein containing a caspase recruitment domain, a pyrin N-terminal homology domain-containing protein, in normal human tissues. J. Histochem. Cytochem. 49, 1269-1275 (2001).
33. Shiohara M, Taniguchi S, Masumoto J et al. ASC, which is composed of a PYD and a CARD, is up-regulated by inflammation and apoptosis in human neutrophils. Biochem. Biophys. Res. Commun. 293, 1314-1318 (2002).
34. Church LD, Cook GP, McDermott MF. Primer: inflammasomes and interleukin-1β in inflammatory disorders. Nat. Clin. Pract. Rheumatol. 4, 34-42 (2008).
35. Shinkai K, McCalmont TH, Leslie KS. Cryopyrin-associated periodic syndromes and autoinflammation. Clin. Exp. Dermatol. 33, 1-9 (2008).
36. Agostini L, Martinon F, Burns K et al. NALP3 forms an IL-1β-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. Immunity 20, 319-325 (2004).
37. Gattorno M, Tassi S, Carta S et al. Pattern of interleukin-1β secretion in response to lipopolysaccharide and ATP before and after interleukin-1 blockade in patients with CIAS1 mutations. Arthritis Rheum. 56, 3138-3148 (2007).
38. Hawkins PN, Lachmann HJ, Aganna E et al. Spectrum of clinical features in Muckle-Wells syndrome and response to anakinra. Arthritis Rheum. 50, 607-612 (2004).
39. Hoffman HM, Rosengren S, Boyle DL et al. Prevention of cold-associated acute inflammation in familial cold autoinflammatory syndrome by interleukin-1 receptor antagonist. Lancet 364, 1779-1785 (2004).
40. Hysi P, Kabesch M, Moffatt MF et al. NOD1 variation, immunoglobulin E and asthma. Hum. Mol. Genet. 14, 935-941 (2005).
41. Hugot JP, Chamaillard M, Zouali H et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411, 599-603 (2001).
42. Rosengren S, Hoffman HM, Bugbee W et al. Expression and regulation of cryopyrin and related proteins in rheumatoid arthritis synovium. Ann. Rheum. Dis. 64, 708-714 (2005).
43. Martinon F, Petrilli V, Mayor A et al. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440, 237-241 (2006).
44. Ohta Y, Hamada Y, Katsuoka K. Expression of IL-18 in psoriasis. Arch. Dermatol. Res. 293, 334-342 (2001).
45. Companjen A, van der Wel L, van der Fits L et al. Elevated interleukin-18 protein expression in early active and progressive plaque-type psoriatic lesions. Eur. Cytokine Netw. 15, 210-216 (2004).
46. Camp RD, Fincham NJ, Cunningham FM et al. Psoriatic skin lesions contain biologically active amounts of an interleukin 1-like compound. J. Immunol. 137, 3469-3474 (1986).
47. Gruaz D, Didierjean L, Grassi J et al. Interleukin 1α and β in psoriatic skin: enzymoimmunoassay, immunoblot studies and effect of systemic retinoids. Dermatologica 179, 202-206 (1989).
48. Feldmeyer L, Keller M, Niklaus G et al. The inflammasome mediates UVB-induced activation and secretion of interleukin-1β by keratinocytes. Curr. Biol. 17, 1140-1145 (2007).
49. Wang B, Feliciani C, Howell BG et al. Contribution of Langerhans cell-derived IL-18 to contact hypersensitivity. J. Immunol. 168, 3303-3308 (2002).
50. Watanabe H, Gaide O, Petrilli V et al. Activation of the IL-1β-processing inflammasome is involved in contact hypersensitivity. J. Invest. Dermatol. 127, 1956-1963 (2007). • Demonstrates inflammasomes as regulators of innate immunity in contact hypersensitivity.
51. Raymond AA, Méchin MC, Nachat R et al. Nine procaspases are expressed in normal human epidermis, but only caspase-14 is fully processed. Br. J. Dermatol. 156, 420-427 (2007).
52. Johansen C, Moeller K, Kragballe K et al. The activity of caspase-1 is increased in lesional psoriatic epidermis. J. Invest. Dermatol. 127, 2857-2864 (2007). • Investigates caspase-1 in lesional psoriatic skin.
53. Kummer JA, Broekhuizen R, Everett H et al. Inflammasome components NALP 1 and 3 show distinct but separate expression profiles in human tissues suggesting a site-specific role in the inflammatory response. J. Histochem. Cytochem. 55, 443-452 (2007). • Demonstrates the expression profile of NALP1 and -3 in the skin.
54. Mizutani H, Black R, Kupper TS. Human keratinocytes produce but do not process pro-interleukin-1 (IL-1) β. Different strategies of IL-1 production and processing in monocytes and keratinocytes. J. Clin. Invest. 87, 1066-1071 (1991).
55. Antonopoulos C, Cumberbatch M, Dearman RJ et al. Functional caspase-1 is required for Langerhans cell migration and optimal contact sensitization in mice. J. Immunol. 166, 3672-3677 (2001).
56. Sutterwala FS, Ogura Y, Szczepanik M et al. Critical role for NALP3/CIAS1/Cryopyrin in innate and adaptive immunity through its regulation of caspase-1. Immunity 24, 317-327 (2006).
57. Yazdi AS, Ghoreschi K, Röcken M. Inflammasome activation in delayed-type hypersensitivity reactions. J. Invest. Dermatol. 127, 1853-1856 (2007).
58. Shimizu H, Banno Y, Sumi N et al. Activation of p38 mitogen-activated protein kinase and caspases in UVB-induced apoptosis of human keratinocyte HaCaT cells. J. Invest. Dermatol. 112, 769-774 (1999).
59. Wang M, Tsai BM, Turrentine MW et al. p38 mitogen activated protein kinase mediates both death signaling and functional depression in the heart. Ann. Thorac. Surg. 80, 2235-2241 (2005).
60. Sekiyama A, Ueda H, Kashiwamura S et al. A stress-induced, superoxide-mediated caspase-1 activation pathway causes plasma IL-18 upregulation. Immunity 22, 669-677 (2005).
61. Kumar S, Boehm J, Lee JC. p38 MAP kinases: key signaling molecules as therapeutic targets for inflammatory diseases. Nat. Rev. Drug Discov. 2, 717-726 (2003).
62. Johansen C, Kragballe K, Westergaard M et al. The mitogen-activated protein kinases p38 and ERK1/2 are increased in lesional psoriatic skin. Br. J. Dermatol. 152, 37-42 (2005).
63. Johansen C, Funding AT, Otkjaer K et al. Protein expression of TNF-α in psoriatic skin is regulated at a posttranscriptional level by MAPK-activated protein kinase 2. J. Immunol. 176, 1431-1438 (2006).
64. Funding AT, Johansen C, Kragballe K et al. Mitogen- and stress-activated protein kinase 2 and cyclic AMP response element binding protein are activated in lesional psoriatic epidermis. J. Invest. Dermatol. 127, 2012-2019 (2007).
65. Funding AT, Johansen C, Kragballe K et al. Mitogen- and stress-activated protein kinase 1 is activated in lesional psoriatic epidermis and regulates the expression of pro-inflammatory cytokines. J. Invest. Dermatol. 126, 1784-1791 (2006).
66. Mariathasan S, Newton K, Monack DM et al. Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature 430, 213-218 (2004).
67. Yamanaka K, Tanaka M, Tsutsui H et al. Skin-specific caspase-1-transgenic mice show cutaneous apoptosis and pre-endotoxin shock condition with a high serum level of IL-18. J. Immunol. 165, 997-1003 (2000). • Characterizes skin-specific caspase-1-transgenic mice.